Table 1.
| AHF (N = 7946) | No AHF (N = 4125) | Total (N = 12071) | P value | |
|---|---|---|---|---|
| Age | 85.0 (80.0, 89.0) | 83.0 (79.0, 88.0) | 84.0 (80.0, 89.0) | <0.01 |
| Age (>85), n (%) | 3500 (44.0%) | 1566 (38.0%) | 5066 (42.0%) | <0.01 |
| Sex (W), n (%) | 4254 (53.5%) | 2113 (51.2%) | 6367 (52.7%) | 0.02 |
| Hypertension, n (%) | 4299 (54.1%) | 1754 (42.5%) | 6053 (50.1%) | <0.01 |
| Ischaemic heart disease, n (%) | 2721 (34.2%) | 597 (14.5%) | 3318 (27.5%) | <0.01 |
| COPD, n (%) | 949 (11.9%) | 1272 (30.8%) | 2221 (18.4%) | <0.01 |
| Atrial fibrillation, n (%) | 4555 (57.3%) | 986 (23.9%) | 5541 (45.9%) | <0.01 |
| Dyslipidaemia, n (%) | 2327 (29.3%) | 820 (19.9%) | 3147 (26.1%) | <0.01 |
| Diabetes, n (%) | 2182 (27.5%) | 785 (19.0%) | 2967 (24.6%) | <0.01 |
| Depression, n (%) | 490 (6.2%) | 324 (7.9%) | 814 (6.7%) | <0.01 |
| Chronic kidney disease, n (%) | 1232 (15.5%) | 276 (6.7%) | 1508 (12.5%) | <0.01 |
| Acute ischaemic stroke, n (%) | 291 (3.7%) | 170 (4.1%) | 461 (3.8%) | 0.21 |
| Glycated haemoglobin (%) | 6.1 (5.7, 7.0) | 6.2 (5.7, 7.1) | 6.1 (5.7, 7.0) | 0.02 |
| ALT (U/L) | 23.0 (16.0, 35.0) | 20.0 (14.0, 30.0) | 22.0 (15.0, 33.0) | <0.01 |
| AST (U/L) | 28.0 (21.0, 40.0) | 25.0 (20.0, 35.0) | 27.0 (21.0, 38.0) | <0.01 |
| Bilirubin (μmol/L) | 12.0 (8.0, 18.0) | 9.0 (6.0, 13.0) | 11.0 (7.0, 16.0) | <0.01 |
| Creatinine clearance (mL/min or mL/min/1.73 m2) | 45.0 (32.0, 62.0) | 64.0 (45.0, 81.0) | 51.0 (35.0, 70.2) | <0.01 |
| Creatinine (μmol/L) | 110.0 (83.0, 152.0) | 84.0 (65.0, 112.0) | 101.0 (75.0, 140.0) | <0.01 |
| CRP (mg/L) | 14.0 (5.0, 40.0) | 37.0 (9.2, 106.7) | 18.3 (6.0, 59.0) | <0.01 |
| Haematocrit (%) | 36.2 (32.4, 40.0) | 38.2 (34.7, 41.5) | 37.0 (33.3, 40.6) | <0.01 |
| Haemoglobin (g/dL) | 11.9 (10.6, 13.2) | 12.6 (11.4, 13.8) | 12.1 (10.9, 13.4) | <0.01 |
| Leukocytes (×10*9/L) | 8.2 (6.5, 10.7) | 9.9 (7.5, 13.4) | 8.8 (6.8, 11.7) | <0.01 |
| Platelets (×10*9/L) | 224.0 (176.0, 281.0) | 244.0 (193.0, 309.0) | 231.0 (182.0, 292.0) | <0.01 |
| Potassium (mmol/L) | 4.3 (3.9, 4.7) | 4.2 (3.9, 4.6) | 4.3 (3.9, 4.7) | <0.01 |
| Sodium (mmol/L) | 139.0 (136.0, 141.0) | 139.0 (136.0, 141.0) | 139.0 (136.0, 141.0) | <0.01 |
| Troponin I (μg/L) | 0.0 (0.0, 0.1) | 0.0 (0.0, 0.1) | 0.0 (0.0, 0.1) | 0.10 |
| Troponin T (ng/L) | 45.0 (29.0, 77.0) | 31.5 (19.0, 57.0) | 42.0 (25.7, 72.0) | <0.01 |
| TSH (mUI/L) | 1.9 (1.1, 3.2) | 1.5 (0.9, 2.5) | 1.8 (1.0, 3.0) | <0.01 |
| NT‐proBNP (ng/L) log | 8.5 (7.8, 9.3) | 6.7 (5.7, 7.8) | 8.1 (7.0, 9.0) | <0.01 |
| BNP (ng/L) log | 6.4 (5.7, 7.1) | 4.9 (4.1, 5.8) | 5.9 (5.0, 6.8) | <0.01 |
| NT‐proBNP (ng/L) | 5021.5 (2412.8, 10642.2) | 832.0 (285.5, 2405.5) | 3308.0 (1094.5, 8092.5) | <0.01 |
| BNP (ng/L) | 607.0 (312.0, 1178.8) | 134.0 (60.2, 318.0) | 383.0 (153.0, 858.2) | <0.01 |
| In‐hospital death, n (%) | 588 (7.4%) | 325 (7.9%) | 913 (7.6%) | 0.35 |
The data are quoted as the number (%), or mean ± SD.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate (mL/min); NT‐proBNP, N terminal pro brain natriuretic peptide.